Search Results - cheng+zhang

1 Results Sort By:
Novel class I HDAC inhibitors that are impervious to glucuronidation for the treatment of hematologic malignancies and inflammatory diseases/disorders
Novel class I HDAC inhibitors that are impervious to glucuronidation for the treatment of hematologic malignancies and inflammatory diseases/disordersTechnology: MUSC researchers have developed a series of potent and selective class I histone deacetylase (HDAC) inhibitors that do not suffer from the genotoxicity, off-target effects, and metabolic inactivation...
Published: 2/1/2017   |   Inventor(s): Chung-Jen (James) Chou, Jesse McClure, Cheng Zhang, Elizabeth Inks
Keywords(s):  
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum